Form 4 for RCUS Arcus Biosciences, Inc.
Accepted 2024-01-02 00:00:00 ET · period of report 2023-12-29 · accession 0001724521-24-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-02 | 2023-12-29 | RCUS | ROSEN TERRY J | CEO, Dir | W - Inherited | $0.00 | +448 | 3.87M | +0.0% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-29 | W | A | 448 | $0.00 | 3,866,974 | D | — | — |